- call +1-201-465-4211
- email sales@mrinsights.biz
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and nasal spray.The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The nasal spray is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis.
Statistic for budesonide in this report includes three product types: nasal spray, inhaler and pill&rectal forms.
Scope of the Report:
This report focuses on the Budesonide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America is the largest consumer in the past years. North America occupied more than 40% consumption market share in 2015. Europe is the second largest region around the world, it occupied about 34% consumption market share in 2015.
There are three type of budesonide product in the market: nasal spray，inhaler and pill&rectal forms. Inhaler has the largest output due to the large asthma treatment market.
AstraZeneca is the leading company in the budesonide market. Its revenue from budesonide is 1.3 billion USD in 2015, occupied more than half of global budesonide market.
The worldwide market for Budesonide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
AstraZeneca
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz
Dr. Falk Pharma
Chiesi Farmaceutici S.p.A
Orion Corporation
Cipla
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Promod Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Nasal Spray
Inhaler
Pill&Rectal Forms
Market Segment by Applications, can be divided into
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
There are 15 Chapters to deeply display the global Budesonide market.
Chapter 1, to describe Budesonide Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Budesonide, with sales, revenue, and price of Budesonide, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Budesonide, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Budesonide market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Budesonide sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Budesonide Introduction
1.2 Market Analysis by Type
1.2.1 Nasal Spray
1.2.2 Inhaler
1.2.3 Pill&Rectal Forms
1.3 Market Analysis by Applications
1.3.1 Respiratory Disease Treatment
1.3.2 Nose Disease Treatment
1.3.3 Inflammatory Bowel Disease Treatment
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Budesonide Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Cosmo Pharmaceuticals
2.2.1 Business Overview
2.2.2 Budesonide Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Cosmo Pharmaceuticals Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Teva
2.3.1 Business Overview
2.3.2 Budesonide Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mylan
2.4.1 Business Overview
2.4.2 Budesonide Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Mylan Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sandoz
2.5.1 Business Overview
2.5.2 Budesonide Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sandoz Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Dr. Falk Pharma
2.6.1 Business Overview
2.6.2 Budesonide Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Dr. Falk Pharma Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Chiesi Farmaceutici S.p.A
2.7.1 Business Overview
2.7.2 Budesonide Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Chiesi Farmaceutici S.p.A Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Orion Corporation
2.8.1 Business Overview
2.8.2 Budesonide Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Orion Corporation Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Cipla
2.9.1 Business Overview
2.9.2 Budesonide Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cipla Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Synmosa Biopharma Corporation
2.10.1 Business Overview
2.10.2 Budesonide Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Synmosa Biopharma Corporation Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Lunan Better Pharmaceutical
2.11.1 Business Overview
2.11.2 Budesonide Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Lunan Better Pharmaceutical Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Shanghai Sine Promod Pharmaceutical
2.12.1 Business Overview
2.12.2 Budesonide Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Shanghai Sine Promod Pharmaceutical Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Budesonide Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Budesonide Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Budesonide Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Budesonide Manufacturer Market Share in 2017
3.3.2 Top 6 Budesonide Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Budesonide Market Analysis by Regions
4.1 Global Budesonide Sales, Revenue and Market Share by Regions
4.1.1 Global Budesonide Sales and Market Share by Regions (2013-2018)
4.1.2 Global Budesonide Revenue and Market Share by Regions (2013-2018)
4.2 North America Budesonide Sales and Growth Rate (2013-2018)
4.3 Europe Budesonide Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Budesonide Sales and Growth Rate (2013-2018)
4.5 South America Budesonide Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Budesonide Sales and Growth Rate (2013-2018)
5 North America Budesonide by Countries
5.1 North America Budesonide Sales, Revenue and Market Share by Countries
5.1.1 North America Budesonide Sales and Market Share by Countries (2013-2018)
5.1.2 North America Budesonide Revenue and Market Share by Countries (2013-2018)
5.2 United States Budesonide Sales and Growth Rate (2013-2018)
5.3 Canada Budesonide Sales and Growth Rate (2013-2018)
5.4 Mexico Budesonide Sales and Growth Rate (2013-2018)
6 Europe Budesonide by Countries
6.1 Europe Budesonide Sales, Revenue and Market Share by Countries
6.1.1 Europe Budesonide Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Budesonide Revenue and Market Share by Countries (2013-2018)
6.2 Germany Budesonide Sales and Growth Rate (2013-2018)
6.3 UK Budesonide Sales and Growth Rate (2013-2018)
6.4 France Budesonide Sales and Growth Rate (2013-2018)
6.5 Russia Budesonide Sales and Growth Rate (2013-2018)
6.6 Italy Budesonide Sales and Growth Rate (2013-2018)
7 Asia-Pacific Budesonide by Countries
7.1 Asia-Pacific Budesonide Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Budesonide Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Budesonide Revenue and Market Share by Countries (2013-2018)
7.2 China Budesonide Sales and Growth Rate (2013-2018)
7.3 Japan Budesonide Sales and Growth Rate (2013-2018)
7.4 Korea Budesonide Sales and Growth Rate (2013-2018)
7.5 India Budesonide Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Budesonide Sales and Growth Rate (2013-2018)
8 South America Budesonide by Countries
8.1 South America Budesonide Sales, Revenue and Market Share by Countries
8.1.1 South America Budesonide Sales and Market Share by Countries (2013-2018)
8.1.2 South America Budesonide Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Budesonide Sales and Growth Rate (2013-2018)
8.3 Argentina Budesonide Sales and Growth Rate (2013-2018)
8.4 Colombia Budesonide Sales and Growth Rate (2013-2018)
9 Middle East and Africa Budesonide by Countries
9.1 Middle East and Africa Budesonide Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Budesonide Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Budesonide Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Budesonide Sales and Growth Rate (2013-2018)
9.3 UAE Budesonide Sales and Growth Rate (2013-2018)
9.4 Egypt Budesonide Sales and Growth Rate (2013-2018)
9.5 Nigeria Budesonide Sales and Growth Rate (2013-2018)
9.6 South Africa Budesonide Sales and Growth Rate (2013-2018)
10 Global Budesonide Market Segment by Type
10.1 Global Budesonide Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Budesonide Sales and Market Share by Type (2013-2018)
10.1.2 Global Budesonide Revenue and Market Share by Type (2013-2018)
10.2 Nasal Spray Sales Growth and Price
10.2.1 Global Nasal Spray Sales Growth (2013-2018)
10.2.2 Global Nasal Spray Price (2013-2018)
10.3 Inhaler Sales Growth and Price
10.3.1 Global Inhaler Sales Growth (2013-2018)
10.3.2 Global Inhaler Price (2013-2018)
10.4 Pill&Rectal Forms Sales Growth and Price
10.4.1 Global Pill&Rectal Forms Sales Growth (2013-2018)
10.4.2 Global Pill&Rectal Forms Price (2013-2018)
11 Global Budesonide Market Segment by Application
11.1 Global Budesonide Sales Market Share by Application (2013-2018)
11.2 Respiratory Disease Treatment Sales Growth (2013-2018)
11.3 Nose Disease Treatment Sales Growth (2013-2018)
11.4 Inflammatory Bowel Disease Treatment Sales Growth (2013-2018)
12 Budesonide Market Forecast (2018-2023)
12.1 Global Budesonide Sales, Revenue and Growth Rate (2018-2023)
12.2 Budesonide Market Forecast by Regions (2018-2023)
12.2.1 North America Budesonide Market Forecast (2018-2023)
12.2.2 Europe Budesonide Market Forecast (2018-2023)
12.2.3 Asia-Pacific Budesonide Market Forecast (2018-2023)
12.2.4 South America Budesonide Market Forecast (2018-2023)
12.2.5 Middle East and Africa Budesonide Market Forecast (2018-2023)
12.3 Budesonide Market Forecast by Type (2018-2023)
12.3.1 Global Budesonide Sales Forecast by Type (2018-2023)
12.3.2 Global Budesonide Market Share Forecast by Type (2018-2023)
12.4 Budesonide Market Forecast by Application (2018-2023)
12.4.1 Global Budesonide Sales Forecast by Application (2018-2023)
12.4.2 Global Budesonide Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Budesonide Picture
Table Product Specifications of Budesonide
Figure Global Sales Market Share of Budesonide by Types in 2017
Table Budesonide Types for
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
